Vaccines, adjuvants and autoimmunity

Pharmacological Research

Volumn 100, Issue , 2015, Pages 190-209

  Guimarães, Luísa Eça ^a   Baker, Britain ^a   Perricone, Carlo ^b   Shoenfeld, Yehuda ^a,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adjuvant; Aluminium; Autoimmune inflammatory syndrome induced by adjuvants; Autoimmunity; Human papilloma virus; Vaccine safety; Vaccines; Vaccinomics

Indexed keywords

ADVAX; ALUMINUM HYDROXIDE; ALUMINUM PHOSPHATE; AS 03; AUTOANTIBODY; BCG VACCINE; BETA2 GLYCOPROTEIN 1; CHOLERA VACCINE; CPG OLIGODEOXYNUCLEOTIDE; FREUND ADJUVANT; HEPATITIS B VACCINE; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; ISCOM; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; MIFAMURTIDE; PATTERN RECOGNITION RECEPTOR; PHOSPHORYL LIPID A; PNEUMOCOCCUS VACCINE; QS 21; SMALLPOX VACCINE; TETANUS TOXOID; TUFTSIN; TYPHOID VACCINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINE; VAXINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ANAPHYLACTOID PURPURA; ANTIPHOSPHOLIPID SYNDROME; AORTA ARCH SYNDROME; ARTHRALGIA; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE INFLAMMATORY SYNDROME INDUCED BY ADJUVANT; AUTOIMMUNITY; AUTOINFLAMMATORY DISEASE; BULLOUS PEMPHIGOID; DECREASED APPETITE; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MODEL; DRUG HYPERSENSITIVITY; ENCEPHALOMYELITIS; EOSINOPHILIC GRANULOMA; EXPERIMENTAL MODEL; FATIGUE; FEVER; GRANULOMATOSIS; GUILLAIN BARRE SYNDROME; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INNATE IMMUNITY; LATENT PERIOD; MEDICAL RESEARCH; MEMORY T LYMPHOCYTE; MENINGOCOCCOSIS; MICROSCOPIC POLYANGIITIS; MOUSE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIPLE SCLEROSIS; MYALGIA; MYELITIS; MYOPATHY; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; NEUROTOXICITY; NONHUMAN; OPTIC NEURITIS; OVARY INSUFFICIENCY; PANCREATITIS; PARESTHESIA; PERSONALIZED MEDICINE; POLYARTERITIS NODOSA; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REVIEW; SLEEP DISORDER; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOCYTOPENIC PURPURA; TRANSITIONAL CELL CARCINOMA; UTERINE CERVIX CANCER; VASCULITIS; ANIMAL; IMMUNOLOGY; PROCEDURES; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; VACCINATION; VACCINES;

EID: 84940026134     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.08.003     Document Type: Review

References (269)

1. Y. Shoenfeld, and D.A. Isenberg The mosaic of autoimmunity Immunol. Today 10 4 1989 123 126 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/2665774
2. S. Kivity, N. Agmon-Levin, M. Blank, and et al. Infections and autoimmunity - friends or foes? Trends Immunol. 30 8 2009 409 414 [Internet] (cited 24.02.15) http://www.ncbi.nlm.nih.gov/pubmed/19643667
3. C. Perricone, S. Colafrancesco, R.D. Mazor, and et al. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects J. Autoimmun. 47 2013 1 16 [Internet] (cited 14.01.15) http://www.ncbi.nlm.nih.gov/pubmed/24238833
4. Y. Shoenfeld, and N. Agmon-Levin ASIA - autoimmune/inflammatory syndrome induced by adjuvants J. Autoimmun 36 1 2011 1 16 [Internet] (cited 23.02.15) http://www.ncbi.nlm.nih.gov/pubmed/20708902
5. E. Israeli, N. Agmon-Levin, M. Blank, and et al. Adjuvants and autoimmunity Lupus 18 13 2009 1217 1225 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19880572
6. R. Glück Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs) Vaccine 17 13-14 1999 1782 1787 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/10194840
7. B. Beutler Interfaces questions and possibilities in Toll-like receptor signalling Nature 430 6996 2004 257 263 [Internet] (cited 23.03.15) http://www.ncbi.nlm.nih.gov/pubmed/15241424
8. P.S. Creticos, J.T. Schroeder, R.G. Hamilton, and et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis N. Engl. J. Med. 355 14 2006 1445 1455 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/17021320
9. V. Alexeev, T. Mucci, and O. Igoucheva Immunotherapeutic strategies for the treatment of malignant melanoma G. Ital. Dermatol. Venereol. 143 2 2008 139 149 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/18833040
10. J.M. Kirkwood, H.A. Tawbi, A.A. Tarhini, and et al. Does pegylated interferon alpha-2b confer additional benefit in the adjuvant treatment of high-risk melanoma? Nat. Clin. Pract. Oncol. 6 2 2015 70 71 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19092800
11. I.Z. Siemion, and A. Kluczyk Tuftsin on the 30-year anniversary of Victor Najjar's discovery Peptides 20 5 1999 645 674 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/10465518
12. J.H. Phillips, G.F. Babcock, and K. Nishioka Tuftsin a naturally occurring immunopotentiating factor. I. In vitro enhancement of murine natural cell-mediated cytotoxicity J. Immunol. 126 3 1981 915 921 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/6893996
13. S. Dagan, E. Tzehoval, M. Fridkin, and et al. Tuftsin and tuftsin conjugates potentiate immunogenic processes: effects and possible mechanisms J. Biol. Response Mod. 6 6 1987 625 636 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/3502474
14. K. Riedl, R. Riedl, A. von Gabain, and et al. The novel adjuvant IC31 strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice Vaccine 26 27-28 2008 3461 3468 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/18495302
15. M.E. Pichichero Improving vaccine delivery using novel adjuvant systems Hum. Vaccin 4 4 2015 262 270 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/18398303
16. A. Ghochikyan, M. Mkrtichyan, I. Petrushina, and et al. Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch Vaccine 24 13 2006 2275 2282 [Internet] (cited 22.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2081151&tool=pmcentrez&rendertype=Abstract
17. S. Zimmermann, O. Egeter, S. Hausmann, and et al. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis J. Immunol. 160 8 1998 3627 3630 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/9558060
18. M. Fridkin, H. Tsubery, E. Tzehoval, and et al. Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy J. Pept. Sci. 11 1 2005 37 44 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/15635725
19. X. Liu, J. Guo, S. Han, and et al. Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin Vaccine 30 46 2012 6527 6533 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22959982
20. K. Pawan, B.B. Ivanov, L. Kabilan, and et al. Construction of a synthetic immunogen: use of the natural immunomodulator polytuftsin in malaria vaccines against RESA antigen of Plasmodium falciparum Vaccine 12 9 1994 819 824 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/7526572
21. K. Lukács, G. Szabó, I. Sonkoly, and et al. Stimulating effect of tuftsin and its analogues on the defective monocyte chemotaxis in systemic lupus erythematosus Immunopharmacology 7 3-4 1984 171 178 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/6469603
22. V.E. Schijns Immunological concepts of vaccine adjuvant activity Curr. Opin. Immunol. 12 4 2000 456 463 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/10899018
23. D.T. O'Hagan, and N.M. Valiante Recent advances in the discovery and delivery of vaccine adjuvants Nat. Rev. Drug Discov. 2 9 2003 727 735 [Internet] (cited 30.03.15) http://www.ncbi.nlm.nih.gov/pubmed/12951579
24. M. Rangachari, and V.K. Kuchroo Using EAE to better understand principles of immune function and autoimmune pathology J. Autoimmun. 45 2013 31 39 [Internet] (cited 11.02.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3963137&tool=pmcentrez&rendertype=Abstract
25. C. Pasare, and R. Medzhitov Toll pathway-dependent blockade of CD4 + CD25 + T cell-mediated suppression by dendritic cells Science 299 5609 2003 1033 1036 [Internet] (cited 10.03.15) http://www.ncbi.nlm.nih.gov/pubmed/12532024
26. D. Fairweather, S. Frisancho-Kiss, and N.R. Rose Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis Rev. Med. Virol. 15 1 2015 17 27 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/15386590
27. D. Cihakova, and N.R. Rose Pathogenesis of myocarditis and dilated cardiomyopathy Adv. Immunol. 99 2008 95 114 [Internet] (cited 20.04.15] http://www.ncbi.nlm.nih.gov/pubmed/19117533
28. D.L. Lamm, D.E. Thor, S.C. Harris, and et al. Bacillus calmette-guerin immunotherapy of superficial bladder cancer J. Urol. 124 1 1980 38 40 [Internet] (cited 16.03.15] http://www.ncbi.nlm.nih.gov/pubmed/6997513
29. N.W. Palm, and R. Medzhitov Pattern recognition receptors and control of adaptive immunity Immunol. Rev. 227 1 2009 221 233 [Internet] (cited 12.03.15] http://www.ncbi.nlm.nih.gov/pubmed/19120487
30. H. Kono, and K.L. Rock How dying cells alert the immune system to danger Nat. Rev. Immunol. 8 4 2008 279 289 [Internet] (cited 10.07.14] http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2763408&tool=pmcentrez&rendertype=Abstract
31. V. Shpacovitch, M. Feld, M.D. Hollenberg, and et al. Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity J. Leukoc. Biol. 83 6 2008 1309 1322 [Internet] (cited 17.04.15] http://www.ncbi.nlm.nih.gov/pubmed/18347074
32. Q.M. Nhu, K. Shirey, J.R. Teijaro, and et al. Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo Mucosal. Immunol. 3 1 2010 29 39 [Internet] (cited 22.04.15] http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2851245&tool=pmcentrez&rendertype=Abstract
33. P. Cruz-Tapias, N. Agmon-Levin, E. Israeli, and et al. Autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA) - animal models as a proof of concept Curr. Med. Chem. 20 32 2013 4030 4036 [Internet] [cited 31.03.15] http://www.ncbi.nlm.nih.gov/pubmed/23992328
34. B.C. Carlson, A.M. Jansson, A. Larsson, and et al. The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats Am. J. Pathol. 156 6 2000 2057 2065 [Internet] [cited 22.04.15] http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1850095&tool=pmcentrez&rendertype=Abstract
35. S. Kleinau, H. Erlandsson, and L. Klareskog Percutaneous exposure of adjuvant oil causes arthritis in DA rats Clin. Exp. Immunol. 96 2 1994 281 284 [Internet] (cited 22.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1534890&tool=pmcentrez&rendertype=Abstract
36. M.M. Griffiths, A.D. Sawitzke, D.S. Harper, and et al. Exacerbation of collagen-induced arthritis in rats by rat cytomegalovirus is antigen-specific Autoimmunity 18 3 1994 177 187 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/7858103
37. C.A. Bersani-Amado, J.A. Barbuto, and S. Jancar Comparative study of adjuvant induced arthritis in susceptible and resistant strains of rats. I. Effect of cyclophosphamide J. Rheumatol. 17 2 1990 149 152 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/2138672
38. F.-J. Authier, S. Sauvat, C. Christov, and et al. AlOH3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic background Neuromuscul. Disord. 16 5 2006 347 352 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/16616846
39. P.N. Anderson, and M. Potter Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane) Nature 222 5197 1969 994 995 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/5789334
40. B. Di, G. enedetto, M. Pierangeli, A. Scalise, and et al. Paraffin oil injection in the body: an obsolete and destructive procedure Ann. Plast. Surg. 49 4 2002 391 396 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/12370645
41. M. Satoh, Y. Kuroda, H. Yoshida, and et al. Induction of lupus autoantibodies by adjuvants J. Autoimmun. 21 1 2003 1 9 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/12892730
42. A. Katzav, S. Kivity, M. Blank, and et al. Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome Lupus 21 2 2012 210 216 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22235055
43. N. Bassi, R. Luisetto, D. Del Prete, and et al. Induction of the ASIA syndrome in NZB/NZWF1 mice after injection of complete Freund's adjuvant (CFA) Lupus 21 2 2012 203 209 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22235054
44. E. Haugarvoll, I. Bjerkås, N.J. Szabo, and et al. Manifestations of systemic autoimmunity in vaccinated salmon Vaccine 28 31 2010 4961 4969 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/20553770
45. T.L. Fodey, P. Delahaut, C. Charlier, and et al. Comparison of three adjuvants used to produce polyclonal antibodies to veterinary drugs Vet. Immunol. Immunopathol. 122 1-2 2008 25 34 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/18063100
46. B.E. Straw, N.J. MacLachlan, W.T. Corbett, and et al. Comparison of tissue reactions produced by Haemophilus pleuropneumoniae vaccines made with six different adjuvants in swine Can. J. Comp. Med. 49 2 1985 149 151 [Internet] (cited 22.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1236138&tool=pmcentrez&rendertype=Abstract
47. L. Hewitson, L.A. Houser, C. Stott, and et al. Delayed acquisition of neonatal reflexes in newborn primates receiving a thimerosal-containing hepatitis B vaccine: influence of gestational age and birth weight AJ. Toxicol. Environ. Health A 73 19 2010 1298 1313 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/20711932
48. L. Luján, M. Pérez, E. Salazar, and et al. Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep Immunol. Res. 56 2-3 2013 317 324 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23579772
49. Z. Khan, C. Combadière, F.-J. Authier, and et al. Slow CCL2-dependent translocation of biopersistent particles from muscle to brain BMC Med. 11 2013 99 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3616851&tool=pmcentrez&rendertype=Abstract
50. C.A. Shaw, and M.S. Petrik Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration J. Inorg. Biochem. 103 11 2009 1555 1562 [Internet] (cited 22.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2819810&tool=pmcentrez&rendertype=Abstract
51. W.J. Lukiw, M.E. Percy, and T.P. Kruck Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture J. Inorg. Biochem. 99 9 2005 1895 1898 [Internet] (cited 14.04.15) http://www.ncbi.nlm.nih.gov/pubmed/15961160
52. C. Exley The pro-oxidant activity of aluminum Free Radic Biol. Med. 36 3 2004 380 387 [Internet] (cited 10.04.15) http://www.ncbi.nlm.nih.gov/pubmed/15036357
53. N. Singla, and D.K. Dhawan Regulatory role of zinc during aluminium-induced altered carbohydrate metabolism in rat brain J. Neurosci. Res. 90 3 2012 698 705 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22108899
54. L. Tomljenovic Aluminum and Alzheimer's disease: after a century of controversy, is there a plausible link? J. Alzheimers Dis. 23 4 2011 567 598 [Internet] (cited 10.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21157018
55. D.P. Perl Exposure to aluminium and the subsequent development of a disorder with features of Alzheimer's disease J. Neurol. Neurosurg. Psychiatry 77 7 2006 811 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2117484&tool=pmcentrez&rendertype=Abstract
56. C. Exley, G. Mamutse, O. Korchazhkina, and et al. Elevated urinary excretion of aluminium and iron in multiple sclerosis Mult Scler 12 5 2006 533 540 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/17086897
57. C.A. Shaw, S. Seneff, S.D. Kette, and et al. Aluminum-induced entropy in biological systems: implications for neurological disease J. Toxicol. 2014 2014 1 [Internet] (cited 24.03.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4202242&tool=pmcentrez&rendertype=Abstract
58. C. Exley, P. Siesjö, and H. Eriksson The immunobiology of aluminium adjuvants: how do they really work? Trends Immunol. 31 3 2010 103 109 [Internet] (cited 20.04.15) http://www.cell.com/article/S1471490609002488/fulltext
59. H. Wen, D. Gris, Y. Lei, and et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling Nat. Immunol. 12 5 2011 408 415 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4090391&tool=pmcentrez&rendertype=Abstract
60. S. Chakraborty, D.K. Kaushik, M. Gupta, and et al. Inflammasome signaling at the heart of central nervous system pathology J. Neurosci. Res. 88 8 2010 1615 1631 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/20127816
61. FAO/WHO (Food and Agriculture Organization/World Health Organization) Summary and conclusions of the sixty-seventh meeting of the Joint FAO/WHO Expert Committee on Food Additives JECFA 2015 [Internet] (cited 30.06.15) ftp://ftp.fao.org/ag/agn/jecfa/jecfa67-final.pdf
62. A. Pineau, B. Fauconneau, A.-P. Sappino, and et al. If exposure to aluminium in antiperspirants presents health risks, its content should be reduced J. Trace Elem. Med. Biol. 28 2 2014 147 150 [Internet] (cited 06.06.15) http://www.ncbi.nlm.nih.gov/pubmed/24418462
63. R.K. Gherardi, M. Coquet, P. Cherin, and et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle Brain 124 2001 1821 1831 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/11522584
64. Y. Wang, and S. Dai Structural basis of metal hypersensitivity Immunol. Res. 55 1-3 2013 83 90 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4040395&tool=pmcentrez&rendertype=Abstract
65. V. Stejskal, R. Hudecek, J. Stejskal, and et al. Diagnosis and treatment of metal-induced side-effects Neuro Endocrinol. Lett. 27 Suppl. 1 2006 7 16 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/17261999
66. J. Clausen Mercury and multiple sclerosis Acta Neurol. Scand. 87 6 1993 461 464 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/8356875
67. J. Prochazkova, I. Sterzl, H. Kucerova, and et al. The beneficial effect of amalgam replacement on health in patients with autoimmunity Neuro Endocrinol. Lett. 25 3 2004 211 218 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/15349088
68. V. Stejskal, K. Ockert, and G. Bjørklund Metal-induced inflammation triggers fibromyalgia in metal-allergic patients Neuro Endocrinol. Lett. 34 6 2013 559 565 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/24378456
69. M. Hybenova, P. Hrda, J. Procházková, and et al. The role of environmental factors in autoimmune thyroiditis Neuro Endocrinol. Lett. 31 3 2015 283 289 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/20588228
70. M. Tomka, A. Machovcová, D. Pelclová, and et al. Orofacial granulomatosis associated with hypersensitivity to dental amalgam Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 112 3 2011 335 341 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21684771
71. J.L. Turk, and H. Baker Nephrotic syndrome due to ammoniated mercury Br. J. Dermatol. 80 9 1968 623 624 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/5676001
72. T.H. Ingalls Endemic clustering of multiple sclerosis in time and place, 1934-1984. Confirmation of a hypothesis Am. J. Forensic Med. Pathol. 7 1 1986 3 8 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/3728417
73. E.C. Somers, M.A. Ganser, J.S. Warren, and et al. Mercury exposure and antinuclear antibodies among females of reproductive age in the United States: NHANES Environ. Health Perspect. 2015 [Internet] (cited 10.05.15) http://www.ncbi.nlm.nih.gov/pubmed/25665152
74. T. Palosuo, T.T. Provost, and F. Milgrom Gold nephropathy: serologic data suggesting an immune complex disease Clin. Exp. Immunol. 25 2 1976 311 318 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1541350&tool=pmcentrez&rendertype=Abstract
75. S.M. Al-Mogairen, S.A. Meo, A.S. Al-Arfaj, and et al. Nickel-induced allergy and contact dermatitis: does it induce autoimmunity and cutaneous sclerosis? An experimental study in Brown Norway rats Rheumatol. Int. 30 9 2010 1159 1164 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19784841
76. US Environmental Protection Agency, Health Assessment Document for Nickel, Washington, DC (1986).
77. C.A. Shaw, and L. Tomljenovic Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity Immunol. Res. 56 2-3 2013 304 316 [Internet] (cited 14.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23609067
78. S.A. Plotkin Six revolutions in vaccinology Pediatr. Infect. Dis. J. 24 1 2015 1 9 [Internet] (cited 264.04.15) http://www.ncbi.nlm.nih.gov/pubmed/15665703
79. R. Rappuoli From Pasteur to genomics: progress and challenges in infectious diseases Nat. Med. 10 11 2004 1177 1185 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/15516917
80. B. Pulendran, S. Li, and H.I. Nakaya Systems vaccinology Immunity 33 4 2010 516 529 [Internet] (cited 23.024.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3001343&tool=pmcentrez&rendertype=Abstract
81. G.A. Poland, R.B. Kennedy, B.A. McKinney, and et al. Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century Semin Immunol. 25 2 2013 89 103 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3752773&tool=pmcentrez&rendertype=Abstract
82. R.M. Jacobson, I.G. Ovsyannikova, P.V. Targonski, and et al. Studies of twins in vaccinology Vaccine 25 16 2007 3160 3164 [Internet] (cited 20.04.15) http://www.ncbi.nlm.nih.gov/pubmed/17284336
83. I.G. Ovsyannikova, and G.A. Poland Vaccinomics current findings, challenges and novel approaches for vaccine development AAPS J. 13 3 2011 438 444 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3160164&tool=pmcentrez&rendertype=Abstract
84. T. Shiina, K. Hosomichi, H. Inoko, and et al. The HLA genomic loci map: expression, interaction, diversity and disease J. Hum. Genet. 54 1 2009 15 39 [Internet] (cited 28.01.15) http://www.ncbi.nlm.nih.gov/pubmed/19158813
85. B. Posteraro, R. Pastorino, P. Di Giannantonio, and et al. The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses Vaccine 32 15 2014 1661 1669 [Internet] (cited 26.03.14) http://www.ncbi.nlm.nih.gov/pubmed/24513009
86. L.G. Meier, H.R. Barthel, and C. Seidl Development of polyarthritis after insertion of silicone breast implants followed by remission after implant removal in 2HLA-identical sisters bearing rheumatoid arthritis susceptibility genes J. Rheumatol. 24 9 1997 1838 1841 [Internet] (cited 30.06.15) http://www.ncbi.nlm.nih.gov/pubmed/9292814
87. J.-M. Anaya, B. Reyes, A.M. Perdomo-Arciniegas, and et al. Autoimmune/auto-inflammatory syndrome induced by adjuvants (ASIA) after quadrivalent human papillomavirus vaccination in Colombians: a call for personalised medicine Clin. Exp. Rheumatol. 2015 [Internet] (cited 11.05.15) http://www.ncbi.nlm.nih.gov/pubmed/25962455
88. T. Avcin, A. Ambrozic, M. Kuhar, and et al. Anticardiolipin and anti-beta(2) glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits Rheumatology (Oxford) 40 5 2001 565 573 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/11371668
89. Z. Karali, S.T. Basaranoglu, Y. Karali, and et al. Autoimmunity and hepatitis A vaccine in children J. Investig. Allergol. Clin. Immunol. 21 5 2015 389 393 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21905502
90. M. Blank, I. Krause, M. Fridkin, and et al. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome J. Clin. Invest. 109 6 2002 797 804 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=150905&tool=pmcentrez&rendertype=Abstract
91. E.O. Koppang, I. Bjerkås, E. Haugarvoll, and et al. Vaccination-induced systemic autoimmunity in farmed Atlantic salmon J. Immunol. 181 7 2008 4807 4814 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/18802084
92. N. Toplak, T. Kveder, A. Trampus-Bakija, and et al. Autoimmune response following annual influenza vaccination in 92 apparently healthy adults Autoimmun. Rev. 8 2 2008 134 138 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/18700173
93. P. Korošec, M. Petrovec, M. Lainščscak, and et al. High non-specific T lymphocyte response to the adjuvanted H1N1 vaccine in comparison with the H1N1/H3N2/B-Brisbane vaccine without adjuvant Scand. J. Immunol. 76 5 2012 497 504 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22862739
94. S.G. Pasoto, A.C. Ribeiro, V.S.T. Viana, and et al. Short and long-term effects of pandemic unadjuvanted influenza A(H1N1) pdm09 vaccine on clinical manifestations and autoantibody profile in primary Sjögren's syndrome Vaccine 31 14 2013 1793 1798 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23395584
95. O. Elkayam, D. Paran, M. Burke, and et al. Pneumococcal vaccination of patients with systemic lupus erythematosus: effects on generation of autoantibodies Autoimmunity 38 7 2005 493 496 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/16373254
96. C.C. Mok, L.Y. Ho, L.S. Fong, and et al. Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study Ann. Rheum. Dis. 72 5 2013 659 664 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22589375
97. A. Soybilgic, K.B. Onel, T. Utset, and et al. Safety and immunogenicity of the quadrivalent HPV vaccine in female systemic lupus erythematosus patients aged 12 to 26 years Pediatr. Rheumatol. Online J. 11 2013 29 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3751269&tool=pmcentrez&rendertype=Abstract
98. P. Martinuc, J. orobic, T. Avcin, B. Bozic, and et al. Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine Clin. Exp. Immunol. 142 2 2005 377 380 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1809502&tool=pmcentrez&rendertype=Abstract
99. M.R. Arbuckle, M.T. McClain, M.V. Rubertone, and et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus N. Engl. J. Med. 349 16 2003 1526 1533 [Internet] (cited 22.06.15) http://www.ncbi.nlm.nih.gov/pubmed/14561795
100. C. Perricone, N. Agmon-Levin, F. Ceccarelli, and et al. Genetics and autoantibodies Immunol. Res. 56 2-3 2013 206 219 [Internet] (cited 30.06.15) http://www.ncbi.nlm.nih.gov/pubmed/23564181
101. S.D. Hajdu, N. Agmon-Levin, and Y. Shoenfeld Silicone and autoimmunity Eur. J. Clin. Invest. 41 2 2011 203 211 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/20880074
102. B. Santucci, C. Valenzano, M. de Rocco, and et al. Platinum in the environment: frequency of reactions to platinum-group elements in patients with dermatitis and urticaria Contact Dermatitis 43 6 2000 333 338 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/11140383
103. M. Lidar, N. Agmon-Levin, P. Langevitz, and et al. Silicone and scleroderma revisited Lupus 21 2 2012 121 127 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22235041
104. R.C.W. Vermeulen, and H.R. Scholte Rupture of silicone gel breast implants and symptoms of pain and fatigue J. Rheumatol. 30 10 2003 2263 2267 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/14528527
105. M. Bekerecioglu, A.M. Onat, M. Tercan, and et al. The association between silicone implants and both antibodies and autoimmune diseases Clin. Rheumatol. 27 2 2008 147 150 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/17610103
106. G. Zandman-Goddard, M. Blank, M. Ehrenfeld, and et al. A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants J. Rheumatol. 26 1 1999 73 77 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/9918243
107. J.W. Cohen Tervaert, and R.M. Kappel Silicone implant incompatibility syndrome (SIIS): a frequent cause of ASIA (Shoenfeld's syndrome) Immunol. Res. 56 2-3 2013 293 298 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23576058
108. M. De, D. attia, V. Del, G.C. ecchio, G. Russo, and et al. Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines Acta Haematol. 123 2 2010 96 109 [Internet] (cited 28.04.15) http://www.ncbi.nlm.nih.gov/pubmed/20029174
109. A.J. Tingle, M. Allen, R.E. Petty, and et al. Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation Ann. Rheum. Dis. 45 2 1986 110 114 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1001829&tool=pmcentrez&rendertype=Abstract
110. P. Ray, S. Black, H. Shinefield, and et al. Risk of chronic arthropathy among women after rubella vaccination. Vaccine safety datalink team JAMA 278 7 1997 551 556 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/9268275
111. E. Gotuzzo, S. Yactayo, and E. Córdova Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years Am. J. Trop. Med. Hyg. 89 3 2013 434 444 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3771278&tool=pmcentrez&rendertype=Abstract
112. Weekly epidemiological record (2013).
113. E. Rafferty, P. Duclos, S. Yactayo, and et al. Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review Vaccine 31 49 2013 5798 5805 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/24079979
114. N.M. Gandhi, A. Morales, and D.L. Lamm Bacillus calmette-guérin immunotherapy for genitourinary cancer BJU Int. 112 3 2013 288 297 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23517232
115. V.R. Kodali, and R.B. Clague Arthritis after BCG vaccine in a healthy woman J. Int. Med. 244 2 1998 183 184 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/10095807
116. E. Kåss, S. Straume, and E. Munthe Dermatomyositis after B.C.G. vaccination Lancet 1 8067 1978 772 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/76775
117. S.S. Kothari Aetiopathogenesis of Takayas's arteritis and BCG vaccination: the missing link? Med. Hypotheses 45 3 1995 227 230 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/8569543
118. L. Bernini, C.U. Manzini, D. Giuggioli, and et al. Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature Autoimmun. Rev. 12 12 2013 1150 1159 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/2381656
119. A. Schattner, A. Gilad, and J. Cohen Systemic granulomatosis and hypercalcaemia following intravesical bacillus calmette-guérin immunotherapy J. Int. Med. 251 3 2002 272 277 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/11886488
120. M.H. Chang, C.J. Chen, M.S. Lai, and et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan childhood hepatoma study group N. Engl. J. Med. 336 26 1997 1855 1859 [Internet] (cited 06.03.15) http://www.ncbi.nlm.nih.gov/pubmed/9197213
121. N. Agmon-Levin, Z. Paz, E. Israeli, and et al. Vaccines and autoimmunity Nat. Rev. Rheumatol. 5 11 2009 648 652 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19865091
122. C. Perricone, and Y. Shoenfeld Hepatitis B vaccination and undifferentiated connective tissue disease: another brick in the wall of the autoimmune/inflammatory syndrome induced by adjuvants (Asia) J. Clin. Rheumatol. 19 5 2013 231 233 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23884184
123. L. Tomljenovic, and C.A. Shaw Y. Shoenfeld, N. Agmon-Levin, L. Tomljenovic, Adverse Reactions to Human Papillomavirus (HPV) Vaccines 1st ed. 2015 Wiley Press New York
124. C. De, N. arvalho, J. Teixeira, C.M. Roteli-Martins, and et al. Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women Vaccine 28 38 2010 6247 6255 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/20643092
125. S. Lee Detection of human papillomavirus L1 gene DNA fragments in postmortem blood and spleen after GardasilReg. vaccination - a case report Adv. Biosci. Biotechnol. 3 8 2012 1214 1224 [Internet] http://www.scirp.org/journal/PaperInformation.aspx?PaperID=25840
126. L. Tomljenovic, and C.A. Shaw Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds? Ann. Med. 45 2 2013 182 193 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22188159
127. D. Mahajan, I. Roomiani, M.S. Gold, and et al. Annual report: surveillance of adverse events following immunisation in Australia Commun. Dis. Intell. Q. Rep. 34 3 2009 259 276 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21090181
128. G. Lawrence, M.S. Gold, R. Hill, and et al. Annual report: surveillance of adverse events following immunisation in Australia Commun. Dis. Intell. Q. Rep. 32 4 2007 371 387 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19374268
129. N. Agmon-Levin, S. Kivity, and Y. Shoenfeld Influenza vaccine and autoimmunity Isr. Med. Assoc. J. 11 3 2015 183 185 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19544711
130. S. Echevarría-Zuno, J.M. Mejía-Aranguré, A.J. Mar-Obeso, and et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis Lancet 374 9707 2009 2072 2079 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19913290
131. A.L. Bischoff, N.V. Følsgaard, C.G. Carson, and et al. Altered response to A(H1N1) pnd09 vaccination in pregnant women: a single blinded randomized controlled trial PLoS One 8 4 2013 e56700 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3630160&tool=pmcentrez&rendertype=Abstract
132. S. Cerpa-Cruz, P. Paredes-Casillas, N. Landeros, E. avarro, and et al. Adverse events following immunization with vaccines containing adjuvants Immunol. Res. 56 2-3 2013 299 303 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23576057
133. T. Duggal, P. Segal, M. Shah, and et al. Antineutrophil cytoplasmic antibody vasculitis associated with influenza vaccination Am. J. Nephrol. 38 2 2013 174 178 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23941822
134. M. Blank, E. Israeli, and Y.A.P.S. Shoenfeld When (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) Lupus 21 7 2012 711 714 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22635209
135. J. Findlow Meningococcal group B vaccines Hum. Vaccin Immunother. 9 6 2013 1387 1388 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3901838&tool=pmcentrez&rendertype=Abstract
136. M. Gottfredsson, I.K. Reynisson, R.F. Ingvarsson, and et al. Comparative long-term adverse effects elicited by invasive group B and C meningococcal infections Clin. Infect. Dis. 53 9 2011 e117 e124 [Internet] (cited 11.03.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3189164&tool=pmcentrez&rendertype=Abstract
137. C. Borja-Tabora, C. Montalban, Z.A. Memish, and et al. Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study BMC Infect. Dis. 13 2013 116 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3599520&tool=pmcentrez&rendertype=Abstract
138. P. Haber, J. Sejvar, Y. Mikaeloff, and et al. Vaccines and Guillain-Barré syndrome Drug Saf. 32 4 2009 309 323 [Internet] (cited 14.03.15) http://www.ncbi.nlm.nih.gov/pubmed/19388722
139. M.J. Goodman, J.D. Nordin, E.A. Belongia, and et al. Henoch-Schölein purpura and polysaccharide meningococcal vaccine Pediatrics 126 2 2010 e325 e329 [Internet] (cited 14.03.15) http://www.ncbi.nlm.nih.gov/pubmed/20624811
140. M. Valdivielso-Ramos, D. Velázquez, A. Tortoledo, and et al. Infantile bullous pemphigoid developing after hexavalent, meningococcal and pneumococcal vaccinations An. Pediatr. (Barcelona) 75 3 2011 199 202 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21676664
141. M. Jit The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis J. Infect. 61 2 2010 114 124 [Internet] (cited 25.03.15) http://www.ncbi.nlm.nih.gov/pubmed/20433866
142. K.L. O'Brien, L.J. Wolfson, J.P. Watt, and et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates Lancet 374 9693 2009 893 902 [Internet] (cited 22.10.15) http://www.ncbi.nlm.nih.gov/pubmed/19748398
143. FDA. Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) Prevnar 13®, http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm201667.htm [Internet] (cited 28.04.15).
144. C.G. Whitney, M.M. Farley, J. Hadler, and et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine N. Engl. J. Med. 348 18 2003 1737 1746 [Internet] (cited 07.04.15) http://www.ncbi.nlm.nih.gov/pubmed/12724479
145. I.F. Cook, D. Pond, and G. Hartel Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults Vaccine 25 25 2007 4767 4774 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/17512098
146. K.A. Bryant, S.L. Block, S.A. Baker, and et al. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine Pediatrics 125 5 2010 866 875 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/20435707
147. S. Mori, Y. Ueki, Y. Akeda, and et al. Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy Ann. Rheum. Dis. 72 8 2013 1362 1366 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3711492&tool=pmcentrez&rendertype=Abstract
148. A. Van, S. ssen, N. Agmon-Levin, O. Elkayam, and et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases Ann. Rheum. Dis. 70 3 2011 414 422 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21131643
149. T.M. Cook, R.T. Protheroe, and J.M. Handel Tetanus a review of the literature Br. J. Anaesth. 87 3 2015 477 487 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/11517134
150. H. Topaloglu, M. Berker, T. Kansu, and et al. Optic neuritis and myelitis after booster tetanus toxoid vaccination Lancet 339 8786 1992 178 179 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/1346027
151. R. Cervera, J.-C. Piette, J. Font, and et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients Arthritis Rheum. 46 4 2002 1019 1027 [Internet] (cited 25.01.15) http://www.ncbi.nlm.nih.gov/pubmed/11953980
152. R. Schwarzenbacher, K. Zeth, K. Diederichs, and et al. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome EMBO J. 18 22 1999 6228 6239 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1171686&tool=pmcentrez&rendertype=Abstract
153. M. Blank, J. Cohen, V. Toder, and et al. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies Proc. Natl. Acad. Sci. U. S. A. 88 8 1991 3069 3073 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=51386&tool=pmcentrez&rendertype=Abstract
154. J.Y. Huh, D.Y. Yi, S.G. Hwang, and et al. Characterization of antiphospholipid antibodies in chronic hepatitis B infection Kor. J. Hematol. 46 1 2011 36 40 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3065625&tool=pmcentrez&rendertype=Abstract
155. P. Tarján, S. Sipka, G. Lakos, and et al. Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus Scand. J. Rheumatol. 35 3 2015 241 243 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/16766374
156. S. Colafrancesco, N. Agmon-Levin, C. Perricone, and et al. Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle Immunol. Res. 56 2-3 2013 200 205 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23733136
157. H. Orbach, N. Agmon-Levin, and G. Zandman-Goddard Vaccines and autoimmune diseases of the adult Discov. Med. 9 45 2010 90 97 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/20193633
158. W.W. Chatham, D.J. Wallace, W. Stohl, and et al. Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial J. Rheumatol. 39 8 2012 1632 1640 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22707609
159. N. Agmon-Levin, Y. Zafrir, Z. Paz, and et al. Ten cases of systemic lupus erythematosus related to hepatitis B vaccine Lupus 18 13 2009 1192 1197 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/1988056
160. L.D.C. Lyrio, M.F.R. Grassi, I.U. Santana, and et al. Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus Rheumatol. Int. 33 2 2013 335 340 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22451033
161. J.C. Jennette, R.J. Falk, P.A. Bacon, and et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides Arthritis Rheum. 65 1 2012 1 11 [Internet] (cited 06.02.15) http://www.ncbi.nlm.nih.gov/pubmed/23045170
162. A. Zaas, P. Scheel, A. Venbrux, and et al. Large artery vasculitis following recombinant hepatitis B vaccination: 2 cases J. Rheumatol. 28 5 2015 1116 1120 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/11361200
163. L. Guillevin, T. Guittard, R. Boura, and et al. Etiology and precipitating factors of necrotizing angiitis with respiratory manifestations. 5 case reports Ann. Med. Int. (Paris) 134 7 1983 625 628 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/6141756
164. F. Ventura, H. Antunes, C. Brito, and et al. Cutaneous polyarteritis nodosa in a child following hepatitis B vaccination Eur. J. Dermatol. 19 4 2015 400 401 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19467971
165. J.F. De Carvalho, R.M.R. Pereira, and Y. Shoenfeld Systemic polyarteritis nodosa following hepatitis B vaccination Eur. J. Int. Med. 19 8 2008 575 578 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19046721
166. D. Miron, D. Fink, and P.J. Hashkes Kawasaki disease in an infant following immunisation with hepatitis B vaccine Clin. Rheumatol. 22 6 2003 461 463 [Internet] (cited 21.04.15) http://www.ncbi.nlm.nih.gov/pubmed/14677029
167. D. Schmöeller, M.W. Keiserman, H.L. Staub, and et al. Yellow fever vaccination and Kawasaki disease Pediatr. Infect. Dis. J. 28 11 2009 1037 1038 [Internet] (cited 28.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19859023
168. L. Beretta, M. Caronni, M. Vanoli, and et al. Churg-strauss vasculitis with brain involvement following hepatitis B vaccination Clin. Exp. Rheumatol. 19 6 2015 757 [Internet] (cited 28.04.15) http://www.ncbi.nlm.nih.gov/pubmed/11791655
169. R. Birck, I. Kaelsch, P. Schnuelle, and et al. ANCA-associated vasculitis following influenza vaccination: causal association or mere coincidence? J. Clin. Rheumatol. 15 6 2009 289 291 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19734734
170. B. Spaetgens, P. van Paassen, and J.W.C. Tervaert Influenza vaccination in ANCA-associated vasculitis Nephrol. Dial Transplant 24 10 2009 3258 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19666908
171. S. Jariwala, N. Vernon, and J. Shliozberg Henoch-Schönlein purpura after hepatitis A vaccination Ann. Allergy Asthma Immunol. 107 2 2015 180 181 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21802028
172. M.I.F. Pimentel, E.C.F.E. Vasconcellos de, and J. Cerbino-Neto Henoch-Schönlein purpura following influenza A H1N1 vaccination Rev. Soc. Bras. Med. Trop. 44 4 2015 531 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21860908
173. T. Watanabe Henoch-Schönlein purpura following influenza vaccinations during the pandemic of influenza A (H1N1) Pediatr. Nephrol. 26 5 2015 795 798 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21120537
174. G. Famularo, G.C. Nicotra, G. Minisola, and et al. Leukocytoclastic vasculitis after influenza vaccination J. Clin. Rheumatol. 12 1 2006 48 50 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/16484885
175. F. Bani-Sadr, I. Gueit, and G. Humbert Vasculitis related to hepatitis A vaccination Clin. Infect. Dis. 22 3 1996 596 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/8853003
176. I. Masse, and M.C. Descoffres Hypersensitivity vasculitis after hepatitis B vaccination Presse Med. 27 20 2015 965 966 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/9767839
177. B.C. Fox, and A. Peterson Leukocytoclastic vasculitis after pneumococcal vaccination Am. J. Infect. Control 26 3 2015 365 366 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/9638297
178. J. Gerecitano, A. Friedman-Kien, and G.D. Chazen Allergic reaction to varicella vaccine Ann. Int. Med. 126 10 1997 833 834 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/9148672
179. T. Somer, and S.M. Finegold Vasculitides associated with infections, immunization, and antimicrobial drugs Clin. Infect. Dis. 20 4 1995 1010 1036 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/7795045
180. A.E. Muñiz Lymphocytic vasculitis associated with the anthrax vaccine: case report and review of anthrax vaccination J. Emerg. Med. 25 3 2003 271 276 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/14585454
181. M. Sedaghat, S. Zarei-Ghanavati, S. Shokoohi, and et al. Panuveitis and dermal vasculitis following MMR vaccination East Mediterr. Health J. 13 2 2015 470 474 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/17684869
182. D.P. Symmons, and K. Chakravarty Can immunisation trigger rheumatoid arthritis? Ann. Rheum. Dis. 52 12 1993 843 844 [Internet] (cited 26.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1005209&tool=pmcentrez&rendertype=Abstract
183. P. Ray, S. Black, H. Shinefield, and et al. Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age Vaccine 29 38 2011 6592 6597 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21763385
184. L. Delavallée, E. Duvallet, L. Semerano, and et al. Anti-cytokine vaccination in autoimmune diseases Swiss Med. Wkly. 2010 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21043003
185. B. Prakken, and S. Albani Exploiting T. cell crosstalk as a vaccination strategy for rheumatoid arthritis Arthritis Rheum. 56 2 2007 389 392 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/17265472
186. G. Chen, N. Li, Y.C.Q. Zang, and et al. Vaccination with selected synovial T cells in rheumatoid arthritis Arthritis Rheum. 56 2 2007 453 463 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/17265481
187. M. Mosca, C. Tani, L. Carli, and et al. Undifferentiated CTD a wide spectrum of autoimmune diseases Best Pract. Res. Clin. Rheumatol. 26 1 2012 73 77 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22424194
188. M. Mosca, C. Tani, L. Carli, and et al. Analysis of the evolution of UCTD to defined CTD after a long term follow-up Clin. Exp. Rheumatol. 31 3 2015 471 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23075608
189. A. Rasheed, E. Lipstein-Kresch, and J. Kalra Undifferentiated connective tissue disease after silicone-gel testicular implantation J. Clin. Rheumatol. 1 5 1995 310 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19078007
190. V. Bruzzese, A. Zullo, and C. Hassan Connective tissue disease following hepatitis B vaccination J. Clin. Rheumatol. 19 5 2013 280 281 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23872550
191. Bolognia Jean, L., JLJ RRP, Dermatology, 3rd ed. (2012).
192. K. Safavi Prevalence of alopecia areata in the first national health and nutrition examination survey Arch. Dermatol. 128 5 1992 702 [Internet] (cited 30.06.15) http://www.ncbi.nlm.nih.gov/pubmed/1575541
193. D.P. Bogdanos, D.S. Smyk, P. Invernizzi, and et al. Tracing environmental markers of autoimmunity: introducing the infectome Immunol. Res. 56 2-3 2013 220 240 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23592050
194. T.A. Rodriguez, and M. Duvic Onset of alopecia areata after Epstein-Barr virus infectious mononucleosis J. Am. Acad. Dermatol. 59 1 2008 137 139 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/18329131
195. L. Hayderi El, N. Nikkels-Tassoudji, and A.F. Nikkels Hair loss after varicella zoster virus infection Case Rep. Dermatol. 5 1 2015 43 47 [Internet] (cited 27.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3604874&tool=pmcentrez&rendertype=Abstract
196. R.P. Wise, K.P. Kiminyo, and M.E. Salive Hair loss after routine immunizations JAMA 278 14 1997 1176 1178 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/9326478
197. J.P. Sundberg, K.A. Silva, W. Zhang, and et al. Recombinant human hepatitis B vaccine initiating alopecia areata: testing the hypothesis using the C3H/HeJ mouse model Vet. Dermatol. 20 2 2009 99 104 [Internet] (cited 27.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2956183&tool=pmcentrez&rendertype=Abstract
198. S. Sánchez-Ramón, J. Gil, M. Cianchetta-Sívori, and et al. Alopecia universalis in an adult after routine tetanus toxoid vaccine Med. Clin. (Barcelona) 136 7 2011 318 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/20451934
199. M. Tuccori, C. Pisani, L. Bachini, and et al. Telogen effluvium following bivalent human papillomavirus vaccine administration: a report of two cases Dermatology 224 3 2012 212 214 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22584489
200. M.R. Razeghinejad, M.H. Nowroozzadeh, M. Sharifi, and et al. Acute-onset madarosis following MMR vaccination J. Pediatr. Ophthalmol. Strabismus 46 2 2015 123 124 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19343978
201. R. Stasi, S. Amadori, J. Osborn, and et al. Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia PLoS Med. 3 3 2006 e24 [Internet] (cited 27.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1326262&tool=pmcentrez&rendertype=Abstract
202. C. Perricone, F. Ceccarelli, G. Nesher, and et al. Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases Immunol. Res. 60 2-3 2014 226 235 [Internet] (cited 29.04.15) http://www.ncbi.nlm.nih.gov/pubmed/25427992
203. M. Yong, W.M. Schoonen, L. Li, and et al. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database Br. J. Haematol. 149 6 2010 855 864 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/20377590
204. G. Russo, V. Miraglia, F. Branciforte, and et al. Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study Pediatr. Blood Cancer 56 2 2011 273 278 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/20830773
205. M. Rinaldi, C. Perricone, O.-D. Ortega-Hernandez, and et al. Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines Lupus 23 6 2014 554 567 [Internet] (cited 30.05.15) http://www.ncbi.nlm.nih.gov/pubmed/24763539
206. M. Tishler, and Y. Shoenfeld Vaccination may be associated with autoimmune diseases Isr. Med. Assoc. J. 6 7 2015 430 432 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/15274537
207. K.T. Coppieters, A. Wiberg, H. von, and M.G. errath Viral infections and molecular mimicry in type 1 diabetes APMIS 120 12 2012 941 949 [Internet] (cited 14.04.15) http://www.ncbi.nlm.nih.gov/pubmed/2305117
208. Childhood immunizations and type 1 diabetes: summary of an Institute for Vaccine Safety Workshop. The Institute for Vaccine Safety Diabetes Workshop Panel, Pediatr. Infect. Dis. J. 18(3) (1999) 217-222. http://www.ncbi.nlm.nih.gov/pubmed/10093941 [Internet] (27.04.15).
209. B. Singh Stimulation of the developing immune system can prevent autoimmunity J. Autoimmun. 14 1 2000 15 22 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/10648113
210. J. Wahlberg, J. Fredriksson, O. Vaarala, and et al. Vaccinations may induce diabetes-related autoantibodies in one-year-old children Ann. N. Y. Acad. Sci. 1005 2003 404 408 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/14679101
211. S.B. Black, E. Lewis, H.R. Shinefield, and et al. Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohort Pediatr. Infect. Dis. J. 21 6 2015 568 569 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/12182385
212. S.K. Duderstadt, C.E. Rose, T.M. Real, and et al. Vaccination and risk of type 1 diabetes mellitus in active component U. S. Military, 2002-2008 Vaccine 30 4 2012 813 819 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22075092
213. Difficulties in Assessing the Relationship, If Any, Between Mumps Vaccination and Diabetes Mellitus in Childhood, PubMed,NCBI, http://www.ncbi.nlm.nih.gov/pubmed/?term=Milne+LM.+2001.+Difficulties+in+assessing+the+relationship%2C+if+any%2C+between+mumps+vaccination+and+diabetes+mellitus+in+childhood.+Vaccine+19%3A1018%E2%80%9325 [Internet] (cited 27.04.15).
214. C. Bardage, I. Persson, A. Ortqvist, and et al. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden BMJ 343 2015 d5956 [Internet] (cited 30.03.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3192001&tool=pmcentrez&rendertype=Abstract
215. M.E. Parent, J. Siemiatycki, R. Menzies, and et al. Bacille calmette-guérin vaccination and incidence of IDDM in Montreal, Canada Diabetes Care 20 5 1997 767 772 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/9135940
216. M. Huppmann, A. Baumgarten, A.-G. Ziegler, and et al. Neonatal bacille calmette-guerin vaccination and type 1 diabetes Diabetes Care 28 5 2005 1204 1206 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/15855590
217. L.C. Da Rosa, F. Chiuso-Minicucci, S.F.G. Zorzella-Pezavento, and et al. Bacille calmette-guérin/DNAhsp65 prime-boost is protective against diabetes in non-obese diabetic mice but not in the streptozotocin model of type 1 diabetes Clin. Exp. Immunol. 173 3 2013 430 437 [Internet] (cited 27.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3949630&tool=pmcentrez&rendertype=Abstract
218. A. Fontana, H. Gast, W. Reith, and et al. Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss? Brain 133 2010 1300 1311 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/20403960
219. A. Katzav, M.T. Arango, S. Kivity, and et al. Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice J. Autoimmun. 45 2013 24 30 [Internet] (cited 07.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23834844
220. M.-T. Arango, S. Kivity, and Y. Shoenfeld Is narcolepsy a classical autoimmune disease? Pharmacol. Res. 92 2015 6 12 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/25447795
221. A. Käll The Pandemrix - narcolepsy tragedy: how it started and what we know today Acta Paediatr. 102 1 2013 2 4 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23016673
222. O. Rozenberg, A. Lerner, A. Pacht, and et al. A novel algorithm for the diagnosis of celiac disease and a comprehensive review of celiac disease diagnostics Clin. Rev. Allergy Immunol. 42 3 2015 331 341 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21279475
223. L. Plot, H. Amital, O. Barzilai, and et al. Infections may have a protective role in the etiopathogenesis of celiac disease Ann. N. Y. Acad. Sci. 1173 2009 670 674 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/1975821
224. L.C. Stene, M.C. Honeyman, E.J. Hoffenberg, and et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study Am. J. Gastroenterol. 101 10 2006 2333 2340 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/17032199
225. M. Dolcino, G. Zanoni, C. Bason, and et al. A subset of anti-rotavirus antibodies directed against the viral protein VP7 predicts the onset of celiac disease and induces typical features of the disease in the intestinal epithelial cell line T84 Immunol. Res. 56 2-3 2013 465 476 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23572432
226. T. Pozo-Rubio, G. de Palma, J.R. Mujico, and et al. Influence of early environmental factors on lymphocyte subsets and gut microbiota in infants at risk of celiac disease; the PROFICEL study Nutr. Hosp. 28 2 2015 464 473 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23822699
227. S.L. Mackie, and C.D. Mallen Polymyalgia rheumatica BMJ 347 2013 f6937 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/24301266
228. W. Rojo-Contreras, E.M. Olivas-Flores, J.I. Gamez-Nava, and et al. Cervical human papillomavirus infection in Mexican women with systemic lupus erythematosus or rheumatoid arthritis Lupus 21 4 2012 365 372 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22020266
229. A. Soriano, E. Verrecchia, A. Marinaro, and et al. Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature Lupus 21 2 2012 153 157 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22235046
230. D. Saadoun, P. Cacoub, D. Mahoux, and et al. Postvaccine vasculitis: a report of three cases Rev. Med. Int. 22 2 2015 172 176 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/11234675
231. H. Torisu, R. Kira, Y. Ishizaki, and et al. Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan Brain Dev. 32 6 2010 454 462 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19942388
232. L. Bennetto, and N. Scolding Inflammatory/post-infectious encephalomyelitis J. Neurol. Neurosurg. Psychiatry 75 Suppl. 1 2015 22 28 [Internet] (cited 27.04.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1765651&tool=pmcentrez&rendertype=Abstract
233. S. Markovic-Plese, B. Hemmer, Y. Zhao, and et al. High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: implications for the initiation of autoimmune response in multiple sclerosis J. Neuroimmunol. 169 1-2 2005 31 38 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/16150497
234. M. Tejada-Simon V, Y.C.Q. Zang, J. Hong, and et al. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis Ann. Neurol. 53 2 2003 189 197 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/12557285
235. K.C. O'Connor, T. Chitnis, D.E. Griffin, and et al. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions J. Neuroimmunol. 136 1-2 2003 140 148 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/12620653
236. H. Rosenmann, N. Grigoriadis, D. Karussis, and et al. Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein Arch. Neurol. 63 10 2006 1459 1467 [Internet] (cited 05.04.15) http://www.ncbi.nlm.nih.gov/pubmed/17030663
237. D. Karussis, U. Vourka-Karussis, R. Mizrachi-Koll, and et al. Acute/relapsing experimental autoimmune encephalomyelitis: induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation Mult Scler 5 1 1999 17 21 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/10096098
238. O. Vera-Lastra, G. Medina, M.D.P. Cruz-Dominguez, and et al. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum Expert Rev. Clin. Immunol. 9 4 2015 361 373 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23557271
239. W. Huynh, D.J. Cordato, E. Kehdi, and et al. Post-vaccination encephalomyelitis: literature review and illustrative case J. Clin. Neurosci. 15 12 2008 1315 1322 [Internet] (cited 19.03.15) http://www.ncbi.nlm.nih.gov/pubmed/18976924
240. F. DeStefano, T. Verstraeten, L.A. Jackson, and et al. Vaccinations and risk of central nervous system demyelinating diseases in adults Arch. Neurol. 60 4 2003 504 509 [Internet] (cited 21.04.15) http://www.ncbi.nlm.nih.gov/pubmed/12707063
241. Y. Mikaeloff, G. Caridade, B. Husson, and et al. Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse Eur. J. Paediatr. Neurol. 11 2 2007 90 95 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/17188007
242. T. Menge, B. Cree, A. Saleh, and et al. Neuromyelitis optica following human papillomavirus vaccination Neurology 79 3 2012 285 287 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22722628
243. A. Altman, M. Szyper-Kravitz, and Y. Shoenfeld HBV vaccine and dermatomyositis: is there an association? Rheumatol. Int. 28 6 2008 609 612 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/18034245
244. M. Sticherling, and C. Erfurt-Berge Autoimmune blistering diseases of the skin Autoimmun. Rev. 11 3 2012 226 230 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21640850
245. V. Ruocco, E. Ruocco, S. Lo, A. chiavo, and et al. Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies Clin. Dermatol. 31 4 2015 374 381 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23806154
246. A.M. Downs, J.T. Lear, C.P. Bower, and et al. Does influenza vaccination induce bullous pemphigoid? A report of four cases Br. J. Dermato. 138 2 1998 363 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/9602897
247. G.R. Chacón, and A.A. Sinha Bullous pemphigoid after herpes zoster vaccine administration: association or coincidence? J. Drugs Dermatol. 10 11 2015 1328 1330 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/22052318
248. I. Bodokh, J.P. Lacour, J.F. Bourdet, and et al. Reactivation of bullous pemphigoid after influenza vaccination Therapie 49 2 2015 154 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/7817351
249. M.C. Dalakas Pathophysiology of autoimmune polyneuropathies Presse Med. 42 6 pt 2 2013 e181 e192 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/23642299
250. J.-P. Stübgen A review on the association between inflammatory myopathies and vaccination Autoimmun. Rev. 13 1 2014 31 39 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/24001753
251. M.B. Yunus Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes Semin Arthritis Rheum. 36 6 2007 339 356 [Internet] (cited 02.03.15) http://www.ncbi.nlm.nih.gov/pubmed/17350675
252. D. Buskila, F. Atzeni, and P. Sarzi-Puttini Etiology of fibromyalgia: the possible role of infection and vaccination Autoimmun. Rev. 8 1 2008 41 43 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/18706528
253. S. Appel, J. Chapman, and Y. Shoenfeld Infection and vaccination in chronic fatigue syndrome: myth or reality? Autoimmunity 40 1 2007 48 53 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/17364497
254. K. Yao, J.R. Crawford, A.L. Komaroff, and et al. Review part 2: human herpesvirus-6 in central nervous system diseases J. Med. Virol. 82 10 2010 1669 1678 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/20827763
255. J.R. Kerr Pathogenesis of parvovirus B19 infection: host gene variability, and possible means and effects of virus persistence J. Vet. Med. B Infect. Dis. Vet. Public Health 52 7-8 2015 335 339 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/16316396
256. M. Andersson, J. Bagby, L. Dyrehag, and et al. Effects of staphylococcus toxoid vaccine on pain and fatigue in patients with fibromyalgia/chronic fatigue syndrome Eur. J. Pain 2 2 1998 133 142 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/10700309
257. P. Magnus, O. Brubakk, H. Nyland, and et al. Vaccination as teenagers against meningococcal disease and the risk of the chronic fatigue syndrome Vaccine 27 1 2009 23 27 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/189840
258. E. Israeli, and A. Pardo The sick building syndrome as a part of the autoimmune (auto-inflammatory) syndrome induced by adjuvants Mod. Rheumatol. 21 3 2011 235 239 [Internet] (cited 25.03.15) http://www.ncbi.nlm.nih.gov/pubmed/21188456
259. J. Cadusseau, N. Ragunathan-Thangarajah, M. Surenaud, and et al. Selective elevation of circulating CCL2/MCP1 levels in patients with longstanding post-vaccinal macrophagic myofasciitis and ASIA Curr. Med. Chem. 21 4 2014 511 517 [Internet] (cited 17.04.15) http://www.ncbi.nlm.nih.gov/pubmed/24083602
260. G. Lange, L.A. Tiersky, J.B. Scharer, and et al. Cognitive functioning in Gulf War Illness J. Clin. Exp. Neuropsychol. 23 2 2015 240 249 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/11309677
261. C. Unwin, N. Blatchley, W. Coker, and et al. Health of UK servicemen who served in Persian Gulf War Lancet 353 9148 1999 169 178 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/9923871
262. G.A. Rook, and A. Zumla Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile? Lancet 349 9068 1997 1831 1833 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/9269228
263. C.J. Phillips, G.R. Matyas, C.J. Hansen, and et al. Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness Vaccine 27 29 2009 3921 3926 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/1937978
264. S. Van Assen, O. Elkayam, N. Agmon-Levin, and et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheuma Autoimmun. Rev. 10 6 2011 341 352 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21182987
265. M.W. Heijstek, Ott, B. de, L.M. ruin, M. Bijl, and et al. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases Ann. Rheum. Dis. 70 10 2011 1704 1712 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/21813547
266. L.M.H. Mota da, A.C.V. Oliveira, R.A.C. Lima, and et al. Vaccination against yellow fever among patients on immunosuppressors with diagnoses of rheumatic diseases Rev. Soc. Bras. Med. Trop. 42 1 2015 23 27 [Internet] (cited 22.04.15) http://www.ncbi.nlm.nih.gov/pubmed/19287931
267. M.H. Buch, J.S. Smolen, N. Betteridge, and et al. Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis Ann. Rheum. Dis. 70 6 2011 909 920 [Internet] (cited 01.03.15) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3086093&tool=pmcentrez&rendertype=Abstract
268. E. Zonneveld-Huijssoon, A. Ronaghy, R. Van, M.A.J. ossum, and et al. Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis Arthritis Rheum. 56 2 2007 639 646 [Internet] (cited 27.04.15) http://www.ncbi.nlm.nih.gov/pubmed/17265499
269. E. Bergfors, B. Trollfors, and A. Inerot Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer Vaccine 22 1 2003 64 69 [Internet] (cited 26.04.15) http://www.ncbi.nlm.nih.gov/pubmed/14604572